Open an account

VanEck Pharmaceutical ETF

PPH · ETF

$116.34+$2.86 (+2.52%)TodayMarket closed ·
Prev close $113.48

About PPH

PPH was created on 2011-12-20 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 1055.92m in AUM and 26 holdings. PPH tracks a market-cap-weighted index of 25 of the largest global pharmaceutical firms.

Issuer
VanEck
Tracks
MVIS US Listed Pharmaceutical 25
Expense ratio
0.36%
Assets under management
$1.09B
Inception
Dec 20, 2011
Asset class
Equity
Website
vaneck.com

PPH key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
393.30K
Volume
601.95K
Open price
$114.96
High today
$116.68
Low today
$114.96
52 Week high
$118.00
52 Week low
$90.74

VanEck Pharmaceutical ETF (PPH) at a glance

As of Oct 20, 2026, VanEck Pharmaceutical ETF (PPH) shares are priced at $116.34, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $114.96 and $116.68. The current price is 1.2% above the day's low and 0.3% below its high.

Volume so far is 601.95K shares, above the average of 393.30K shares a day.

Over the past year VanEck Pharmaceutical ETF has ranged from $90.74 to $118.00, and now sits 94% of the way up that range.

PPH news

  • Stjepan Kalinic

    Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

  • Vandana Singh

    Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery

  • Nabaparna Bhattacharya

    What's Going On With Merck Stock Tuesday?

  • Rishabh Mishra

    Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'

  • Chandrima Sanyal

    Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk

  • Rishabh Mishra

    Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'

  • Chandrima Sanyal

    Trump's Weight-Loss Drug Push May Put These ETFs On A Diet

  • Rishabh Mishra

    Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.